Senti Biosciences Inc.
SNTI
Get informed when a big investor buys or sells
+ FollowMarket Cap$25.02M
Close$
$-0.06
105.7% downside
Current Fair Value
105.7% downsideOvervalued by 105.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $25.02 Million |
|---|---|
| Enterprise Value | $21.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.73 |
| Beta | 2.1 |
| Outstanding Shares | 30,971,573 |
Return
| Return on Equity | -2009.63% |
|---|---|
| Return on Assets | -134.80% |
| Return on Invested Capital | -230.57% |
Valuation & Multiples
| P/E Ratio | -0.57 |
|---|---|
| PEG | 0.82 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.4 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 2.3 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$20,534
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$14,934
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.97%0% |
|---|---|
| Total Invested | $357,795▼ 33.18% |
| Investors Holding | 10% |
ESG Score
No data
About Senti Biosciences Inc.
4 employees